Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 1
2019 1
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
MicroRNAs related to androgen metabolism and polycystic ovary syndrome.
Sørensen AE, Udesen PB, Wissing ML, Englund ALM, Dalgaard LT. Sørensen AE, et al. Chem Biol Interact. 2016 Nov 25;259(Pt A):8-16. doi: 10.1016/j.cbi.2016.06.008. Epub 2016 Jun 5. Chem Biol Interact. 2016. PMID: 27270454 Review.
Polycystic ovary syndrome (PCOS) is a frequent endocrine disorder in women. PCOS is associated with altered features of androgen metabolism, increased insulin resistance and impaired fertility. ...Our understanding of miRNAs, particularly in
Polycystic ovary syndrome (PCOS) is a frequent endocrine disorder in women. PCOS is associated with altered features of
miRNA Profiling Reveals miRNA-130b-3p Mediates DENND1A Variant 2 Expression and Androgen Biosynthesis.
McAllister JM, Han AX, Modi BP, Teves ME, Mavodza GR, Anderson ZL, Shen T, Christenson LK, Archer KJ, Strauss JF. McAllister JM, et al. Endocrinology. 2019 Aug 1;160(8):1964-1981. doi: 10.1210/en.2019-00013. Endocrinology. 2019. PMID: 31184707 Free PMC article.
Polycystic ovary syndrome (PCOS) is a common endocrine disorder of reproductive-age women involving overproduction of ovarian androgens and, in some cases, from the adrenal cortex. ...Ingenuity® Pathway Analysis Core Pathway and Network Analyses sugges
Polycystic ovary syndrome (PCOS) is a common endocrine disorder of reproductive-age women involving overproduction of o
MicroRNA-27a-3p affects estradiol and androgen imbalance by targeting Creb1 in the granulosa cells in mouse polycytic ovary syndrome model.
Wang M, Liu M, Sun J, Jia L, Ma S, Gao J, Xu Y, Zhang H, Tsang SY, Li X. Wang M, et al. Reprod Biol. 2017 Dec;17(4):295-304. doi: 10.1016/j.repbio.2017.09.005. Epub 2017 Oct 28. Reprod Biol. 2017. PMID: 29089199
Polycystic ovary syndrome (PCOS) is a common endocrine abnormality in women characterized by a menstrual disturbance with chronic anovulation and hyperandrogenism, polycystic ovaries, and insulin resistance. MicroRNAs (miRNAs) are important fine
Polycystic ovary syndrome (PCOS) is a common endocrine abnormality in women characterized by a menstrual disturbance wi
MicroRNA Species in Follicular Fluid Associating With Polycystic Ovary Syndrome and Related Intermediary Phenotypes.
Sørensen AE, Wissing ML, Englund AL, Dalgaard LT. Sørensen AE, et al. J Clin Endocrinol Metab. 2016 Apr;101(4):1579-89. doi: 10.1210/jc.2015-3588. Epub 2016 Jan 15. J Clin Endocrinol Metab. 2016. PMID: 26771704 Free PMC article.
CONTEXT: Polycystic ovary syndrome (PCOS) has a largely unknown etiology and presents with a clinical heterogeneous patient group. ...Bioinformatic target analysis points to an involvement of these miRNAs in biological pathways involving regulation of …
CONTEXT: Polycystic ovary syndrome (PCOS) has a largely unknown etiology and presents with a clinical heterogeneous pat …
Decreased microRNA-125b-5p disrupts follicle steroidogenesis through targeting PAK3/ERK1/2 signalling in mouse preantral follicles.
Zhang X, Xiao H, Zhang X, E Q, Gong X, Li T, Han Y, Ying X, Cherrington BD, Xu B, Liu X, Zhang X. Zhang X, et al. Metabolism. 2020 Jun;107:154241. doi: 10.1016/j.metabol.2020.154241. Epub 2020 Apr 15. Metabolism. 2020. PMID: 32304754
BACKGROUND: Hyperandrogenism is one of the major characteristics of polycystic ovary syndrome (PCOS). Abnormal miR-125b-5p expression has been documented in multiple diseases, but whether miR-125b-5p is associated with aberrant steroidogenesis in preantral fo …
BACKGROUND: Hyperandrogenism is one of the major characteristics of polycystic ovary syndrome (PCOS). Abnormal miR-125b …
miRNAs as a novel clinical biomarker and therapeutic targets in polycystic ovary syndrome (PCOS): A review.
Abdalla M, Deshmukh H, Atkin SL, Sathyapalan T. Abdalla M, et al. Life Sci. 2020 Aug 1;259:118174. doi: 10.1016/j.lfs.2020.118174. Online ahead of print. Life Sci. 2020. PMID: 32745529 Review.
Polycystic ovary syndrome (PCOS) is the most prevalent endocrine disorder in females of the reproductive age. PCOS is commonly manifested as ovulatory dysfunction, clinical and biochemical excess androgen level, and polycystic ovaries. Metabo
Polycystic ovary syndrome (PCOS) is the most prevalent endocrine disorder in females of the reproductive age. PCOS is c
Feedback